SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001123292-17-000280
Filing Date
2017-01-31
Accepted
2017-01-31 15:41:49
Documents
1
Group Members
ATHYRIUM CAPITAL HOLDINGS, LLCATHYRIUM CAPITAL MANAGEMENT, LPATHYRIUM GP HOLDINGS LLCATHYRIUM OPPORTUNITIES ASSOCIATES II LPJEFFREY A. FERRELL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A aegerion13g-01302017.htm SC 13G/A 185605
  Complete submission text file 0001123292-17-000280.txt   187417
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85739 | Film No.: 17560996
SIC: 2834 Pharmaceutical Preparations

Mailing Address 530 FIFTH AVENUE, FLOOR 25 NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, FLOOR 25 NEW YORK NY 10036 212-402-6925
Athyrium Opportunities II Acquisition LP (Filed by) CIK: 0001629077 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A